Join
Live feed
·
PRReleasevia Quantisnow
Incyte Corp. logo
Mirum Pharmaceuticals Inc. logo

Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026

ByQuantisnow·Wall Street's wire, on your screen.
INCY· Incyte Corp.MIRM· Mirum Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INCY (Incyte Corp.), MIRM (Mirum Pharmaceuticals Inc.) and more on Quantisnow.